A Dose Escalation Study of Intranasal Neuropeptide Y in Post Traumatic Stress Disorder (PTSD)
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
This study is designed to investigate the safety of intranasal administration of NPY using a
dose escalation, randomized, double-blinded, placebo-controlled crossover design in a
medication-free, symptomatic PTSD group.